Thank you very much for your continued support of our company.
We will hold a briefing session jointly with GN Group and Gyre Therapeutics for institutions.

・Date and time: December 23, 2024 (Monday)
・Speakers: Our Director and CFO Tomoya Kitagawa, Gyre Therapeutics CFO Ruoyu Chen
・Target audience: Institutions

If there are undisclosed facts, we will promptly disclose them from the perspective of strengthening information dissemination and fair disclosure.